The treatment landscape for food allergy has advanced considerably in recent years. While strict avoidance of trigger foods and quick use of epinephrine remain the cornerstones of management, new therapeutic options are emerging, and a growing pipeline of treatments continues to expand what may be possible for patients in the future.

At the same time, there have been important innovations in epinephrine delivery. In addition to traditional needle-based autoinjectors, newer options—such as needle-free nasal sprays and other delivery methods under development—are providing more flexibility and may improve access and ease of use during emergencies.

Diagnostic approaches are also evolving. New testing methods are being developed that go beyond identifying a food allergy to better predict the severity of reactions and individual risk, moving care toward a more precise and personalized model.